Tag Archives: Yi Chen

Analysts Are Bullish on Top Healthcare Stocks: EyePoint Pharmaceuticals (EYPT), RedHill Biopharma (RDHL)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on EyePoint Pharmaceuticals (EYPT – Research Report), RedHill Biopharma (RDHL – Research Report) and OncoCyte (OCX – Research Report) with bullish sentiments. EyePoint

H.C. Wainwright Thinks Aslan Pharmaceuticals’ Stock is Going to Recover

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Aslan Pharmaceuticals (ASLN – Research Report) today and set a price target of $8.00. The company’s shares closed last Monday at $2.12, close to its 52-week low of $1.42. According

Analysts Are Bullish on Top Healthcare Stocks: Clearside Biomedical (CLSD), Enveric Biosciences (ENVB)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Clearside Biomedical (CLSD – Research Report) and Enveric Biosciences (ENVB – Research Report) with bullish sentiments. TipRanks has tracked 36,000 company insiders

H.C. Wainwright Thinks AzurRx BioPharma’s Stock is Going to Recover

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on AzurRx BioPharma (AZRX – Research Report), with a price target of $2.00. The company’s shares closed last Friday at $0.54, close to its 52-week low

Analysts Are Bullish on These Healthcare Stocks: EyePoint Pharmaceuticals (EYPT), Sorrento Therapeutics (SRNE)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on EyePoint Pharmaceuticals (EYPT – Research Report) and Sorrento Therapeutics (SRNE – Research Report) with bullish sentiments. EyePoint Pharmaceuticals (EYPT) In a report

Veru (VERU) Receives a Rating Update from a Top Analyst

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Veru (VERU – Research Report), with a price target of $21.00. The company’s shares closed last Friday at $8.19. According to TipRanks.com, Chen is a